How to Spot a Stock Market Bubble 101: Raymond James Just Placed an $800 Price Target on SpaceX, Valuing Elon Musk's Company at $10.5 Trillion

SpaceX raised a record $85.7B in its June 12 IPO, but Raymond James’ $800 2031 price target implies ~451% upside from the July 10 close and a ~10.5T valuation. The article flags bubble risk: SpaceX hasn’t proven a sustainable operating model beyond Starlink, xAI is cash-burning, and SpaceX trades at ~50x this year’s forecast sales despite no history of sustaining very high P/S multiples for new tech leaders. While AI/space TAM (cited at $28.5T) supports long-term optionality, near-term valuation and delivery overhangs make the outlook cautious.

Analysis

The important signal is not the company-specific valuation call; it is that a record-scale listing can reset the private-market strike price for every late-stage AI and “deep tech” asset still living on long-dated TAM narratives. In the next few weeks, that tends to help the capital-markets complex first: underwriters, exchanges, and anyone with a distribution franchise can monetize the frenzy before fundamentals are tested. But that benefit is usually front-loaded; once investors demand proof of cash conversion, the same pipeline can stall abruptly.

The bigger losers are duration-heavy names whose bull case depends on perpetually rising terminal multiples rather than near-term earnings. TSLA is the cleanest public proxy because it trades on optionality, brand, and Musk credibility; if the market starts discounting those promises more heavily, the multiple compression can arrive before any earnings revision. NVDA is less directly exposed operationally, but it is the margin-of-safety benchmark for the entire AI complex: if speculative end-markets cool, the market will ask whether AI capex is being financed by real returns or by narrative recycling.

Contrarian view: the bubble thesis may be early if the listing actually lowers the cost of capital and extends the runway for adjacent infrastructure spend. That would favor RJF/NDAQ in the short run and could keep the AI basket bid for another quarter. The falsifier is simple: if post-IPO demand persists through the first lockup window and private-market marks hold, the “end-stage bubble” call is premature; if secondary prints soften or guidance from AI-adjacent names disappoints, the de-rating can become self-reinforcing over 1-3 months.

Key Decisions for Investors

• Short SPCX on post-IPO strength for a 1-3 month mean-reversion trade; use a tight stop if the stock holds above the listing range and secondary supply is absorbed. Risk/reward improves if borrow is tight and implied vol is still cheap.
• Buy RJF or NDAQ on any weakness as a fee-pool beneficiary of renewed issuance; this is a cleaner near-term expression than chasing speculative AI exposure. Falsifier: a sharp drop in announced IPOs or weaker-than-expected ECM fees over the next quarter.
• Reduce or hedge TSLA into any spike tied to AI/space enthusiasm; it is the highest-beta public proxy for “promise premium” compression. If the market begins rewarding delivered cash flow over optionality, TSLA should underperform the quality factor.
• Put NVDA on watch rather than a full short: only press a bearish position if AI capex commentary, hyperscaler spend, or gross margin guidance starts to roll over. Without that confirmation, the risk/reward is more of a hedge than a standalone short.
• If options become liquid, consider SPCX put spreads expiring after the first lockup catalyst rather than outright short stock; this limits squeeze risk while keeping exposure to valuation normalization.